AI channel feed – Endpoints News

AI channel feed

The latest healthcare SPAC comes in at $200M with a laser focus on artificial intelligence

4 years ago

London AI-focused BenevolentAI going public in Europe via $438M SPAC deal

4 years ago

'We're in': Roche and Genentech join forces on a multibillion-dollar discovery pact with a brash AI upstart

4 years ago

Transpacific AI biotech makes its Series A debut — putting $86M in the bank

4 years ago

Sanofi continues mRNA push in wake of Covid vaccine setback, partnering with China tech giant Baidu

4 years ago

Sanofi inks major AI deal to improve clinical development odds with $270M cash investment

4 years ago

Koch leads mammoth $215M infusion into AI startup boasting 'largest database' of immune cells

4 years ago

As AI continues to entice Big Pharma, a Carlyle-led drugmaker syndicate shells out $430M for cloud computing player

4 years ago

Big Pharma companies join hands with Amazon on new Israel-based AI incubator

4 years ago

Exscientia tees up an IPO for its AI drug discovery platform, likely not willing to settle for just $100M

4 years ago

After attracting multiple Chinese pharma partners, XtalPi grabs another $400M to refine AI for drug discovery

4 years ago

Deep Genomics, now flush with cash, plans to take dozens of RNA therapies to the clinic

4 years ago

A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision oncology

5 years ago

A Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see

5 years ago

With a new $255M megaround in hand, Alex Zhavoronkov has big plans for Insilico. Are they feasible?

5 years ago

Exscientia spends SoftBank's cash in bid to edge out AI rivals

5 years ago

Flagship and Khosla Ventures team up for biotech's latest SPAC, with Valo Health winning a blank check ticket to Nasdaq

5 years ago

Tim Lu is ready to take his AI-focused biotech to the next level with first big fundraising round

5 years ago

Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step

5 years ago

Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board

5 years ago

Andrew Radin orchestrates his AI discovery platform's pivot to R&D with a harmonious name change and eyes on the clinic

5 years ago

Fueled with a fresh half-billion dollars as AI investments boom, Exscientia is hitting the gas on drug development

5 years ago

Laying claim to another AI 'first,' Exscientia tees up an I/O drug for the clinic

5 years ago

With fresh investor cash in hand, Volastra partners with Microsoft to develop metastatic cancer biomarker platform

5 years ago

First page Previous page 8 9 101112 13 14 Next page Last page